2019 Head Lice Infestation (Pediculosis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 58 pages | ID: 25DAAB23336EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Head Lice Infestation (Pediculosis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Head Lice Infestation (Pediculosis). It presents in-depth analysis of Head Lice Infestation (Pediculosis) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Head Lice Infestation (Pediculosis).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Head Lice Infestation (Pediculosis) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Head Lice Infestation (Pediculosis)

The research work is prepared through extensive and continuous research on Head Lice Infestation (Pediculosis) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Head Lice Infestation (Pediculosis) patients are identified
• The report includes panorama of Head Lice Infestation (Pediculosis) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Head Lice Infestation (Pediculosis) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Head Lice Infestation (Pediculosis) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Head Lice Infestation (Pediculosis) Clinical Trials by Region
  2.2.2 Average Enrollment of Head Lice Infestation (Pediculosis) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Head Lice Infestation (Pediculosis) Treatment, 2019

3. REGION WISE HEAD LICE INFESTATION (PEDICULOSIS) CLINICAL TRIALS

3.1 Asia Pacific Head Lice Infestation (Pediculosis) Clinical Trials by Country
3.2 Europe Head Lice Infestation (Pediculosis) Clinical Trials by Country
3.3 North America Head Lice Infestation (Pediculosis) Clinical Trials by Country
3.4 Middle East and Africa Head Lice Infestation (Pediculosis) Clinical Trials by Country
3.5 South and Central America Head Lice Infestation (Pediculosis) Clinical Trials by Country

4. HEAD LICE INFESTATION (PEDICULOSIS) CLINICAL TRIAL TRENDS

4.1 Start Year wise Head Lice Infestation (Pediculosis) Clinical Trials
4.2 Phase wise Head Lice Infestation (Pediculosis) Clinical Trials
4.3 Trial Status wise Head Lice Infestation (Pediculosis) Clinical Trials
4.4 Trial Type wise Head Lice Infestation (Pediculosis) Clinical Trials

5. HEAD LICE INFESTATION (PEDICULOSIS) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Head Lice Infestation (Pediculosis) Trials by Year
5.2 Average Enrollment in Head Lice Infestation (Pediculosis) Trials by Phase
5.3 Average Enrollment in Head Lice Infestation (Pediculosis) Trials by Status
5.4 Average Enrollment in Head Lice Infestation (Pediculosis) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN HEAD LICE INFESTATION (PEDICULOSIS) CLINICAL TRIALS

6.1 Head Lice Infestation (Pediculosis) Trials by Sponsor Type
6.2 Head Lice Infestation (Pediculosis) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Head Lice Infestation (Pediculosis) Trials- Phase
7.2 Head Lice Infestation (Pediculosis) Trials- Phase
7.3 Head Lice Infestation (Pediculosis) Trials- Phase
7.4 Head Lice Infestation (Pediculosis) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Head Lice Infestation (Pediculosis) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Figure 7: North America – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Figure 9: Head Lice Infestation (Pediculosis) Clinical Trials by Phase
Figure 10: Head Lice Infestation (Pediculosis) Clinical Trials by Trial Status
Figure 11: Head Lice Infestation (Pediculosis) Clinical Trials by Type
Figure 12: Head Lice Infestation (Pediculosis) Clinical Trials by Sponsor Type
Figure 13: Head Lice Infestation (Pediculosis) Clinical Trials by Leading Sponsors
Figure 14: Head Lice Infestation (Pediculosis) Average Enrollment by Phase
Figure 15: Head Lice Infestation (Pediculosis) Average Enrollment by Trial Status
Figure 16: Head Lice Infestation (Pediculosis) Average Enrollment by Type
Figure 17: Head Lice Infestation (Pediculosis)- Average Enrolment by Type of Sponsors
Figure 18: Head Lice Infestation (Pediculosis)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Head Lice Infestation (Pediculosis) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Table 5: Europe – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Table 7: North America – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Head Lice Infestation (Pediculosis) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Head Lice Infestation (Pediculosis) Average Enrollment by Phase
Table 15: Head Lice Infestation (Pediculosis) Average Enrollment by Trial Status
Table 16: Head Lice Infestation (Pediculosis) Average Enrollment by Type
Table 17: Head Lice Infestation (Pediculosis)- Average Enrolment by Type of Sponsors
Table 18: Head Lice Infestation (Pediculosis)- Enrolment by Leading Sponsors